| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $34.7M | -3.6% |
| Cost of Revenue | $6.3M | -76.9% |
| Gross Profit | -$5.7M | -118.5% |
| R&D Expense | $10.6M | -51.6% |
| SG&A Expense | $35.1M | +125.4% |
| Operating Income | -$53.6M | -523.5% |
| Pre-tax Income | -$64.4M | -438.8% |
| Income Tax | $473K | +126.3% |
| Net Income | -$55.4M | -271.8% |
| EPS (Basic) | $1.91 | +223.7% |
| EPS (Diluted) | $1.91 | +223.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $837K | -84.2% |
| Accounts Receivable | $88K | -99.8% |
| Inventory | $34K | -71.7% |
| Current Assets | $4.1M | -91.2% |
| Total Assets | $14.6M | -84.0% |
| Current Liabilities | $16.4M | +3.1% |
| Total Liabilities | $35.5M | +12.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.8M | +40.5% |
| Capital Expenditures | $2.1M | -83.1% |
| Investing Cash Flow | -$3.7M | +73.8% |
| Financing Cash Flow | $13.6M | -65.6% |
| Free Cash Flow | -$16.9M | +54.7% |
| Stockholders' Equity |
| -$21.0M |
| -176.1% |